. Sequences of 2'-O-Me RNA probes investigated in this study and their MALDI-TOF MS data. Table S2 . Sequences of fluorescent probes investigated in this study and their MALDI-TOF MS data.
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Fig. S1. UV-based melting analysis of m 6 A-containing probes (1a, 2a) and their nonmethylated counterparts (1b, 2b).
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Fig. S2
. UV-based melting analysis of m 6 A-containing probes (3a, 4a) and their nonmethylated counterparts (3b, 4b). 6 A-containing probes (5a, 6a) and their nonmethylated counterparts (5b, 6b). 
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Fig. S3. UV-based melting analysis of m
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RNA m 6 A quantification by dot-blot analysis. S38 Table S1 . Sequences of 2'-O-Me RNA probes investigated in this study and their MALDI-TOF MS data. non-methylated probe 5b (grey line) were measured at total strand concentrations between 1-50 µM under physiologically-relevant conditions (10 mM sodium phosphate buffer containing 150 mM NaCl, pH 7.4). Van't Hoff analysis of 5a and 5b revealed concentration-dependent Tms, implying that both probes exist predominantly as bimolecular duplex structures under our experimental conditions. The thermodynamic data were derived from 1/Tm versus ln(strand concentration) plot, assuming a two-state process. (b) The UV melting and thermodynamic analyses of 6a (black line) and 6b (grey line) were determined as described above. Both probes again exhibited concentration-dependent Tm, implying that they exist predominantly as bimolecular duplex structures under our experimental conditions. S9 non-methylated probe 7b (grey line) were measured at total strand concentrations between 1-50 µM under physiologically-relevant conditions (10 mM sodium phosphate buffer containing 150 mM NaCl, pH 7.4). Van't Hoff analysis of 7a and 7b revealed concentration-dependent Tms, implying that both probes exist predominantly as bimolecular duplex structures under our experimental conditions. The thermodynamic data were derived from 1/Tm versus ln(strand concentration) plot, assuming a two-state process. (b) The UV melting profiles of methylated probe 8a (red line) and non-methylated probe 8b (pink line)
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were determined as described above. Whereas 8a showed a concentration-independent Tm, which is characteristic of a monomolecular hairpin structure, its non-methylated equivalent 8b exhibited a concentration-dependent Tm, implying a bimolecular duplex structure. The thermodynamic data of 8a was obtained from α (the fraction of strands remaining hybridised)
versus temperature plot by curve fitting to a two-state transition model, whilst that of 8b was derived from 1/Tm versus ln(strand concentration) plot, assuming a two-state process. S10 
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Materials and Methods
Synthesis and purification of 2'-O-methyl RNA probes
All oligonucleotide probes used in this study were synthesised on an Applied Biosystem 394 DNA/RNA synthesizer using standard β-cyanoethyl phosphoramidite chemistry. All synthesiser reagents and 2'-O-methyl phosphoramidites were purchased from Glen Research.
2'-O-(1-pyrenylmethyl)uridine phosphoramidite was synthesised according to literature procedure. 1 The oligonucleotides were synthesised on a CPG solid support using a standard 1 μmole phosphoramidite cycle of acid-catalysed detritylation, coupling, capping, and iodine and solvent B (100 mM triethylammonium acetate buffer, pH 6.5 with 15% acetonitrile) with a flow rate of 5 mL/ min. All purified oligonucleotides were characterized by MALDI-MS and capillary gel electrophoresis, and were found to be at least 95% pure. The MALDI-MS data for all probes investigated in this study are summarised in Tables S1 and S2 .
Preparation of oligonucleotide probe samples:
The lyophilised oligonucleotides were reconstituted in 10 mM sodium phosphate buffer (pH 7.4) solution containing 150 mM NaCl. Their concentrations were determined by UV absorbance at 260 nm (A260) using a NanoDrop ND-1000 UV-Visible Spectrophotometer.
Extinction coefficients were calculated using the nearest neighbour approximation; the extinction coefficients of oligonucleotides containing methylated bases were assumed to be the same as those containing unmodified bases. The extinction coefficients of oligonucleotides containing U p was measured using the extinction coefficients for pyrene at 340 nm (340 = 4.7
x 10 4 M -1 cm -1 ). For oligonucleotides that contain two U p (e.g. m 6 A-probe) the sum of extinction coefficients for two pyrenes at 340 nm (340 = 9.4 x 10 4 M -1 cm -1 ) were used.
FTO inhibitor synthesis
The FTO inhibitors (24PDCA, Rhein, IOX3 and isonicotinic acid) investigated in this study were purchased from Sigma-Aldrich. LipotF and ethyl LipotF was synthesised as previously described by us. 2 The 1 H NMR, 13 C NMR and MS data are consistent with the published data.
All inhibitors were found to be at least 95% pure.
Human FTO expression and purification
Full length human FTO was expressed and purified as previously reported, with modifications. containing 500 mM NaCl, 40 mM imidazole and 5 mM β-mercaptoethanol (β-ME). The cells were then disrupted by sonication on ice, and the cell lysate centrifuged and filtered. FTO was then purified from the resulting supernatant using Ni affinity chromatography (GE healthcare).
Further purification of FTO was achieved by gel filtration using a HiLoad superdex 200 26/60 (GE healthcare) in a 25 mM Tris buffer (pH 7.5) containing 100 mM NaCl, 5% (v/v) glycerol and 5 mM β-ME.
Human ALKBH2 expression and purification
Human ALKBH2 was expressed and purified as previously reported, with modifications. mM β-ME. The cells were then disrupted by sonication on ice, and the cell lysate centrifuged and filtered. ALKBH2 was purified from the crude cell lysate by Ni affinity chromatography (GE healthcare), with elution achieved by application of gradient to 500 mM imidazole. This was followed by anion chromatography using a 5 mL HiTrap Q HP column (GE healthcare),
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with elution achieved by application of gradient to 1 M NaCl. Further purification was achieved by gel filtration using a HiLoad superdex 75 26/60 (GE healthcare) in a buffer of 10 mM Tris, pH 8.0, containing 100 mM NaCl and 5 mM β-ME. ALKBH256-258 has previously been shown to be catalytically active. 4 
Human ALKBH3 expression and purification
Full length human ALKBH3 was expressed and purified as previously reported, with modifications. 2, 3 Full length human ALKBH3 was sub-cloned into pET28a to generate a His6-tagged ALKBH31-286 construct, which was transformed into E. coli BL21 (DE3) Rosetta cells.
The transformed cells were grown at 37 °C and 200 rpm until an OD600 of 0.6 was reached.
ALKBH3 expression was then induced by addition of 0.5 mM isopropyl β-D-1-thiogalactopyranoside (IPTG, Gold Biotechnology). Cell growth was continued at 37 °C for 4 h, after which the cells were harvested by centrifugation and the resulting cell pellet was stored at -80 °C. The frozen cell pellets were thawed and re-suspended to homogeneity in 50 mM Sodium Phosphate, pH 8.0, 300 mM NaCl, 10 mM imidazole and 5 mM β-ME. The cells were then disrupted by sonication on ice, and the cell lysate centrifuged and filtered. ALKBH3 was then purified from the resulting supernatant using Ni affinity chromatography (GE healthcare).
with elution achieved by application of gradient to 500 mM imidazole. Further purification was achieved by gel filtration using a HiLoad superdex 75 16/60 (GE healthcare) in a buffer of 25 mM Sodium Phosphate buffer, pH 8.0 containing 150 mM NaCl, 5% (v/v) glycerol and 5 mM β-ME.
Human ALKBH5 expression and purification
Human ALKBH5 (encompassing residues 66-292) was expressed and purified as previously reported, with modifications. and 5 mM β-ME. The cells were then disrupted by sonication on ice, and the cell lysate centrifuged and filtered. ALKBH5 was purified from the crude cell lysate by Ni affinity chromatography (GE healthcare), with elution achieved by application of gradient to 500 mM imidazole. This was followed by anion chromatography using a 5 mL HiTrap Q HP column S30 (GE healthcare), with elution achieved by application of gradient to 1 M NaCl. Further purification was achieved by gel filtration using a HiLoad superdex 75 26/60 (GE healthcare) in a buffer of 20 mM Tris, pH 8.0, 100 mM NaCl and 5 mM β-ME. ALKBH566-292 has previously been shown to be catalytically active. 
Human METTL14 expression and purification
Human METTL14 (encompassing residues 1-399) was expressed and purified as previously reported, with modifications. (GE healthcare) in a 50 mM Bis-Tris buffer (pH 7.0) containing 100 mM NaCl, 5% (v/v) glycerol and 5 mM β-ME.
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NSUN2 and DNMT2 proteins
Full length human NSUN2 protein (encompassing residues 1-767) was purchased from Origene Technologies, Inc. USA.
Full length human DNMT2 protein (encompassing residues 1-391 containing N-terminal His tag) was purchased from abcam plc. UK.
UV-based melting analysis
The melting of each RNA probes was performed on a Cary 3000 UV-Visible Melting transitions were generally found to be reproducible for all probes.
Analysis of thermodynamic data from UV melting experiments
The thermodynamic data for bimolecular duplex structures e.g demethylated probe 16b was analysed as previously described, with modifications. 6 The melting transitions for duplex structures were assumed to proceed in a two-state manner, and to obey the van't Hoff's equation below.
A plot of 1/Tm versus ln(total strand concentration) gives a straight line, where the slope is R/ΔH° and the y-intercept is ΔS°/ΔH°. Data were fitted using linear least-squares minimisation using GraphPad Prism. The free Gibbs energy (ΔG°) were calculated at 37 °C (310.15 K) using the following equation.
∆°= ∆°− ∆°
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The thermodynamic data for monomolecular hairpin structures e.g m 6 A-probe, m 1 A-probe, m 3 T-probe, and m 6 2A-probe was analysed as previously described, with modifications. 7 The experimental fluorescence versus temperature curves were first converted into a fraction of strands remaining hybridized (α) versus temperature curves. This were then fitted to a twostate transition model, where ΔH° and ΔS° values may be obtained.
Circular dichroism (CD) spectroscopy of the conformational probes
The CD spectra for the probes were obtained with a JASCO J-810 spectropolarimeter. The measurements were carried out with 5 μM probes in a 10 mM sodium phosphate buffer (pH 7.4) containing 150 mM NaCl at 25 °C. The concentrations were determined by UV absorbance at 260 nm (A260) using a NanoDrop ND-1000 UV-Visible Spectrophotometer. The probe solutions were first heated to 90 °C for 5 min, and re-annealed by slow cooling to 4 °C at a rate of 1 °C/min. CD spectra were then recorded in quartz cuvettes (path length 1 mm, 400 μL) from 200 nm to 350 nm at 4 °C using a 10 nm/min scan speed, a spectral band width of 1 nm and a time constant of 4 s. All the spectra were subtracted with the buffer blank and smoothed using the Savitsky-Golay algorithm (polynomial order 10).
Non-denaturing polyacrylamide gel electrophoresis (PAGE) analysis
Annealed oligonucleotides were loaded to 20% native polyacrylamide gel and electrophoresis was performed at 4 °C in Tris/Borate/EDTA (TBE) running buffer (90 mM Tris, pH 8.3, 90 mM boric acid and 5 mM EDTA). The gel were stained with SYBR® Gold Nucleic Acid Gel Stain and visualized by Gel Dock XR + (Bio-Rad) and Image Lab 4.0 software (Bio-Rad).
Fluorescence analysis of the probes
Fluorescence was performed in a quartz cuvette using a fluorescence spectrophotometer. The fluorescence emission spectra (λem = 350-530 nm) of the probes were recorded at 5 μM strand concentration in 10 mM sodium phosphate buffer containing 150 mM NaCl, pH 7.4, 37°C.
Background fluorescence spectra were acquired after the probe has been incubated for 5 min at 37 °C. The time course of fluorescence activation was recorded immediately after the addition of enzymes (0.5 μM). An average of five scans was recorded using an excitation slit width of 5.0 nm, emission slit width of 2.5 nm, and a scan speed of 600 nm/min.
Determination of fluorescence quantum yields of the probes
The fluorescence quantum yields (ΦF) of the probes were calculated using the equation below, as previously described. 8, 9 The reported quantum yields are an average of three measurements within ±10%.
Where ΦF(PBA) is the cross-calibrated value for the fluorescence quantum emission yield of pyrenebutanoic acid (PBA) in MeOH. Under our experimental conditions, the fluorescence quantum yield of PBA was determined to be 0.061, which is highly consistent with the reported value of 0.065. 
High-throughput m 6 A-probe assay (in vitro)
The 
For IC50 determination:
Eight different concentrations of inhibitors were used (0, 1, 3, 10, 30, 100, 300, 1000 µM). The
IC50s were then calculated from the variation in fluorescence at different inhibitor concentrations, using nonlinear regression, with normalized dose-response fit on GraphPad Prism 6.0™. The assay was performed in triplicate for each inhibitor concentration.
For the determination of Z' factor:
The Z' factor for our m 6 A-probe assay was calculated using the method described by Zhang et al. 10 A total of 40 independent assays were run with either LipotF (positive control) or DMSO (negative control). The Z' factor was then calculated using the equation below. The following guideline was used to interpret the Z' factor.
A Z' factor between 0.5 and 1.0 indicates an excellent assay.
A Z' factor between 0 and 0.5 indicates a marginal assay.
A Z' factor < 0 indicates too much signal overlap between the positive and negative controls for the assay to be useful.
HPLC-based demethylase assay
The assay was modified from previously reported method. reaction. The Michaelis-Menten curve was fitted using non-linear regression, and the kinetic constants (Vmax, Km) of the substrate was estimated using GraphPad Prism. All reactions were performed at 37 ºC in triplicate and were adjusted to ensure that less than 20% of the substrate was consumed.
Methyltransferase activity assay (with METTL3, METTL14, NSUN2 and DNMT2)
The methyltransferase activity assay was carried out in as previously described, with modifications. 11 The reaction was performed triplicate in 50 μL of reaction mixture containing in a humidified incubator containing 5% CO2 environment, as previously described. HepG2 whole cell lysate preparation.
HepG2 cell lysate was prepared by homogenisation in a modified RIPA lysis buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediamine tetraacetic acid, 1 mM phenylmethylsulfonyl flouride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 µg/mL of aprotinin, 5 µg/mL of leupeptin). Cell debris was removed by centrifugation. Total protein concentration was determined by a Bradford assay.
3T3-L1 pre-adipocyte differentiation
3T3-L1 pre-adipocytes (ATCC) were grown in DMEM containing 10% fetal bovine serum (FBS), penicillin (100 U/mL) and streptomycin (100 μg/mL) until confluence, as previously described. 13 To induce differentiation, cells that were two days' post-confluence (designated as day 0) were exposed to differentiation medium containing containing 0.5 mmol/L 3-isobutyl-1-methylxanthine (IBMX), 1 μmol/L dexamethasone, 1 μg/mL insulin, 2 μmol/L rosiglitazone and 10% FBS for 3 days. At the end of day 3, culture medium was replaced with DMEM supplemented only with 10 μg/mL insulin and 10% FBS, and replenished every other day. By day 10, at least 90% of the cells had accumulated lipid droplets and have differentiated into mature adipocytes.
To follow the dynamic changes in endogenous FTO activity and cellular m 6 A levels during adipogenesis:
The m 6 A-probe (10 μM) was delivered into the cells at different time points of adipogenesis (Day 0, 3, 6, 9), followed by analyses with fluorescence microscopy and flow cytometry, as described below.
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Delivery of m 6 A-probe into cells
The m 6 A-probe was delivered into living cells using a reversible permeabilisation method with streptolysin-O (SLO), as previously described. 14 This method was reported to be more rapid and efficient compared with conventional transfection methods. SLO was first activated by adding 5 mM of TCEP to 2 U/mL of SLO for 30 min at 37°C. Cells that were grown in a 4-chamber well (~2 x 10 5 cells per well; 80% confluency) were incubated for 10 min with 200 μL of serum free medium containing 0.2 U/mL of activated SLO and 10 μM of m 6 A-probe or control probe 22a. The cells were then resealed by adding 0.5 mL of growth medium and incubated for a further 1 h at 37°C (unless otherwise specified). The cells were then washed with 1x PBS before analysis with fluorescence microscopy or flow cytometry as described below.
Fluorescence microscopy
Fluorescence images were acquired using a Nikon BioStation IM-Q live cell imaging system equipped with 20x and 63x oil immersion objective lens. The DAPI filter setting was used (i.e. λex = 340-380 nm, dichroic mirror allowing passage of λ > 400 nm, and λem 435-485nm). For each fluorescence image, the corresponding transmitted light image was also acquired.
Quantification of images was performed using the Biostation IM multichannel software.
Fluorescence intensity was measured by only collecting average gray values for regions exhibiting fluorescence. All experiments were performed in triplicates and the mean fluorescence intensities were normalised to that of the control.
Flow cytometry
Cells that were pre-treated with m 6 A-probe (10 μM) or control probe 22a (10 μM; as described above) were collected by trypsinisation at 37 °C with 5% CO2, washed with PBS media, resuspended in PBS media and then analysed using a BD LSRFortessa™ flow cytometer (BD Bioscience). Fluorescence was measured using an excitation laser of 355 nm, and a 450/50 bandpass emission filter. Acquisition was stopped when 20,000 events per sample were acquired. The fluorescence data were then analysed using BD FACS software.
Real-time fluorescence m 6 A-probe assays in living cells
The HepG2 cells were pre-incubation with various concentrations (0 μM, 25 μM, 100 μM) of ethyl LipotF (a selective, cell permeable FTO inhibitor developed in our lab) 2 for 1 h at 37 °C These concentrations were shown to be non-toxic in various cell lines. 
Western blot analysis
Cells were lysed using mammalian lysis buffer (Sigma-Aldrich), and immunoblotting was performed using standard protocol. The primary antibodies used were purchased from commercial sources: Mouse monoclonal anti-FTO (Abcam, ab92821), rabbit polyclonal anti-ALKBH5 (Sigma-Aldrich), and anti-GAPDH antibody (Cell Signalling; loading control).
Membranes were washed with TBST and incubated with either horseradish peroxidase (HRP)-conjugated anti-rabbit IgG antibody (Bio-Rad) or HRP-conjugated anti-mouse IgG antibody (Bio-Rad) for 2 h at room temperature. Enhanced chemiluminescence substrates (Luminata Crescendo, EMD Millipore) were then applied, and the signals exposed to autoradiography film. The immunoblots were then quantified by densitometric analyses using ImageJ software.
RNA m 6 A quantification by dot-blot analysis
Total RNA was isolated from the cells with TRIZOL reagent (Invitrogen), as previously described. 13 The mRNA was then isolated from total RNA using the Dynabeads® mRNA Purification Kit following the manufacturer's instructions. The concentration of purified mRNA was then determined with NanoDrop and the mRNA serially diluted to 50 ng/μL and 25 ng/μL using RNase-free water. For dot-blot analysis, the mRNA was first denatured by heating at 95 ºC in a heat block for 3 min, followed by immediate chilling on ice to prevent the re-formation of secondary structures of mRNA. 2 μL of the mRNA was spotted on an ImageJ and statistical analysis was based on three replicates.
